Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > On-Demand Supplier Webinar

Biomarkers of Metabolic Syndrome in Clinical Trials

Published: 14-Feb-2011 | Format: Webinar | Document type: Supplier Webinar
Related applications: Phase I-II , Phase III-IV , Preclinical
Pacific Biomarkers, Inc.

PBI scientists will discuss latest developments in biomarkers for metabolic syndrome. Topics: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) Dysfunctional HDL biomarkers in metabolic syndrome, and 3) Kidney Injury Markers and their usefulness in diabetic nephropathy. Attendees would include scientists and physicians involved in drug-development with focus on biomarker selections for clinical trials.


  • Amar A. Sethi

    Amar A Sethi

    Vice President Research and Development

    Pacific Biomarkers, Inc.

  • Dorota Schranz

    Dorota Schranz

    Director Biomarker Development & Validations

    Pacific Biomarkers, Inc.

  • Timothy Carlson

    Timothy Carlson

    Laboratory Director/Senior Director of Biomarker Innovation

    Pacific Biomarkers, Inc.

Supplier's Info Centre